Freeline Therapeutics Company

Freeline Therapeutics works with systematic AAV-based gene therapy, which is a type of virus programmed to direct genes where they need to go. Their pipeline focuses on treating inherited diseases, such as Haemophilia, Fabry Disease, and Gaucher Disease.
Technology: P4 Medicine
Industry: Gene Therapy
Headquarters: Stevenage, Herefordshire, United Kingdom
Founded Date: 2015
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 9
Total Funding: $276M
Estimated Revenue: $1M to $10M
Last Funding Type: Series C

Visit Website
Register and Claim Ownership